publication . Article . Other literature type . 2012

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

Lloyd J. Old; Hirokazu Matsushita; Hirokazu Matsushita; Michael C. Wendl; Ravindra Uppaluri; Elaine R. Mardis; Daniel C. Koboldt; Yee Shiuan Chen; Mark J. Smyth; Mark J. Smyth; ...
Open Access
  • Published: 08 Feb 2012 Journal: Nature, volume 482, pages 400-404 (issn: 0028-0836, eissn: 1476-4687, Copyright policy)
  • Publisher: Springer Science and Business Media LLC
Cancer immunoediting, the process whereby the immune system controls tumour outgrowth and shapes tumour immunogenicity, is comprised of three phases: elimination, equilibrium and escape1–5. Although many immune components that participate in this process are known, its underlying mechanisms remain poorly defined. A central tenet of cancer immunoediting is that T cell recognition of tumour antigens drives the immunologic destruction or sculpting of a developing cancer. However, our current understanding of tumour antigens comes largely from analyses of cancers that develop in immunocompetent hosts and thus may have already been edited. Little is known about the a...
free text keywords: Article, Immunoediting, Cancer research, Immunology, Cancer, medicine.disease, medicine, Immune system, Biology, Immunogenicity, T cell, medicine.anatomical_structure, Cell, Antigen, Expression cloning
36 references, page 1 of 3

Shankaran, V. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001; 410: 1107-11 [PubMed]

Dunn, GP, Bruce, AT, Ikeda, H, Old, LJ, Schreiber, RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002; 3: 991-8 [OpenAIRE] [PubMed]

Koebel, CM. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 2007; 450: 903-7 [OpenAIRE] [PubMed]

Vesely, MD, Kershaw, MH, Schreiber, RD, Smyth, MJ. Natural Innate and Adaptive Immunity to Cancer. Annu Rev Immunol. 2011; 29: 235-271 [PubMed]

Schreiber, RD, Old, LJ, Smyth, MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011; 331: 1565-70 [PubMed]

Futreal, PA. A census of human cancer genes. Nat Rev Cancer. 2004; 4: 177-83 [OpenAIRE] [PubMed]

Chen, AC, Herschman, HR. Tumorigenic methylcholanthrene transformants of C3H/10T1/2 cells have a common nucleotide alteration in the c-Ki-ras gene. Proc Natl Acad Sci U S A. 1989; 86: 1608-11 [OpenAIRE] [PubMed]

Tuveson, DA. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 2004; 5: 375-87 [OpenAIRE] [PubMed]

Kirsch, DG. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med. 2007; 13: 992-7 [PubMed]

Ley, TJ. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008; 456: 66-72 [OpenAIRE] [PubMed]

Ding, L. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010; 464: 999-1005 [OpenAIRE] [PubMed]

Shah, SP. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 2009; 461: 809-13 [OpenAIRE] [PubMed]

Lee, W. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature. 2010; 465: 473-7 [PubMed]

Pleasance, ED. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 2010; 463: 184-90 [OpenAIRE] [PubMed]

Totoki, Y. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011; 43: 464-9 [PubMed]

36 references, page 1 of 3
Any information missing or wrong?Report an Issue